Dopesick

Richard Sackler initiates the launch of the potent painkiller OxyContin, while a rural physician becomes familiar with the drug, a coal miner envisions her future, a DEA agent investigates the black market for pills, and federal prosecutors consider opening an investigation into OxyContin.

OxyContin's market presence is challenged as Purdue Pharma's influence spreads into Finch Creek, prompting DEA agent Bridget to act beyond her official duties as a criminal investigation into the drug begins.

Doctor Finnix starts reducing Betsy's OxyContin dosage, while Bridget observes the drug's impact on local communities. Rick and Randy explore the rise of "pain societies," and Richard Sackler, seeing increasing sales, begins to expand his ambitions for the medication.

Rising concerns over OxyContin abuse lead to declining sales, a key marketing claim faces scrutiny from prosecutors, and Finnix starts to doubt the drug's safety.

Bridget intensifies efforts to combat the national OxyContin crisis by directly challenging Purdue Pharma, while Rick and Randy work to identify a whistleblower inside the company to strengthen their case.

Richard Sackler confronts a major financial threat to Purdue Pharma as Bridget continues her campaign against the FDA. Meanwhile, Finnix reevaluates his priorities while Betsy battles her addiction, and Rick and Randy uncover a shocking piece of evidence.

Richard Sackler and Purdue Pharma employ strategic efforts to avoid regulatory restrictions on their opioid, while Bridget makes progress in her investigation. Betsy faces personal turmoil, Finnix pursues alternative strategies, and Rick and Randy prepare for a criminal prosecution.

Rick and Randy's investigation into Purdue Pharma intensifies, putting Richard Sackler's business at risk, while activists escalate their efforts against the company and Finnix works to support his community affected by the opioid crisis.